Correlation between HbA1c and high sensitivity C-reactive protein in type 2 diabetes mellitus patients: a cross-sectional study at tertiary care hospital in western Rajasthan
DOI:
https://doi.org/10.18203/2320-6012.ijrms20260969Keywords:
Type 2 diabetes mellitus, HbA1c, HSCRP, Lipid profile, InflammationAbstract
Background: Type 2 diabetes mellitus (T2DM) is associated with chronic low-grade inflammation, increasing cardiovascular risk. High-sensitivity C-reactive protein (HSCRP) is a reliable inflammatory biomarker. This study aimed to evaluate the correlation between HbA1c and HSCRP and its association with lipid profile in T2DM patients.
Methods: This cross-sectional study was conducted at Government Medical College and Bangur Hospital, Pali, Rajasthan, over one year. A total of 123 patients aged 18-75 years with T2DM were included. Patients were categorized into controlled (HbA1c<7.5%) and uncontrolled (HbA1c≥7.5%) groups. HbA1c, HSCRP, and lipid profile were measured using standard laboratory methods. Statistical analysis was performed using SPSS version 25, and Pearson’s correlation was applied.
Results: Among 123 patients, 50.4% had controlled and 49.6% had uncontrolled diabetes. Mean HSCRP levels were significantly higher in the uncontrolled group (4.86±2.37 mg/L vs 2.63±0.43 mg/L; p<0.001). Uncontrolled diabetes was associated with significantly higher total cholesterol and triglycerides and lower HDL levels (p<0.001). A strong positive correlation was observed between HSCRP and HbA1c (r=0.961, p<0.001), triglycerides (r=0.889), and total cholesterol (r=0.731), while a negative correlation was seen with HDL (r=−0.827).
Conclusions: Poor glycemic control is strongly associated with increased systemic inflammation and adverse lipid profile. HSCRP can serve as an important marker for cardiovascular risk assessment in T2DM patients.
Metrics
References
Harrison’s Principles of Internal Medicine. 21st ed. Chapter 403: Epidemiology and global considerations. New York: McGraw Hill. 2024;3096.
American Heart Association. Cardiovascular disease statistics. Available at: http://www.americanheart.org/presenter.jhtml?identifier=4478. Accessed on 02 March 2026.
Rubin E, Farber JL, editors. Essential Pathology. 2nd ed. Philadelphia: JB Lippincott. 1995.
Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST elevation myocardial infarction. J Am Coll Cardiol. 2007;50(7):e1-157.
NA. Role of cardiovascular risk factors in prevention and treatment of macrovascular disease in diabetes. American Diabetes Association. Diabetes Care. 1989;12(8):573-9. DOI: https://doi.org/10.2337/diacare.12.8.573
Ana ML, Eridan S, Carol LF, Agnaluce M, Angela H, Luis A. Association between elevated serum C-reactive protein and triglyceride levels in young subjects with type 1 diabetes. Diabetes Care. 2006;29(2):424-6. DOI: https://doi.org/10.2337/diacare.29.02.06.dc05-2033
Baba MM, Balogun MO, Kolawole BA, Ikem RT, Arogundade FA, Adebayo RA. Relationship between C-reactive protein and body mass index in Nigerians with type II diabetes mellitus. Niger J Clin Med. 2012;4(3): 72305193. DOI: https://doi.org/10.4314/njcm.v4i3.3
Baranwal JK, Maskey R, Majhi S, Lamsal M, Baral N. Association between level of HbA1c and lipid profile in T2DM patients attending diabetic OPD at BPKIHS. Health Renaissance. 2017;13(3):16-23. DOI: https://doi.org/10.3126/hren.v13i3.17923
Barzilay JI, Abraham L, Heckbert SR, Cushman M, Kuller LH, Resnick HE, et al. The relation of markers of inflammation to the development of glucose disorders in the elderly. Diabetes. 2001;50:2384-9. DOI: https://doi.org/10.2337/diabetes.50.10.2384
Bhaskar S, Tarafdar HA, Kumar M, Astik SK. Study to determine the relation between HbA1c, lipid profile and CRP in individuals with type 2 diabetes mellitus in a tertiary care hospital. Int J Med Biomed Stud. 2021;5(3):73-7. DOI: https://doi.org/10.32553/ijmbs.v5i3.1816
Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med. 1988;318:1315-21. DOI: https://doi.org/10.1056/NEJM198805193182007
Burchardt P, Zurawski J, Zuchowski B, Kubacki T, Murawa D, Wiktorowicz K, et al. Low-density lipoprotein, its susceptibility to oxidation and role in atherosclerotic plaque formation. Arch Med Sci. 2013;9:151-8. DOI: https://doi.org/10.5114/aoms.2013.33176
Shen Q, He T, Li T. Synergistic effects of overweight/obesity and high hemoglobin A1c on elevated high-sensitivity C-reactive protein in Chinese adults: a cross-sectional study. Front Nutr. 2023;10:1156404. DOI: https://doi.org/10.3389/fnut.2023.1156404
Badimon L, Peña E, Arderiu G, Padró T, Slevin M, Vilahur G, et al. C-reactive protein in atherothrombosis and angiogenesis. Front Immunol. 2018;9:430. DOI: https://doi.org/10.3389/fimmu.2018.00430
Downloads
Published
How to Cite
Issue
Section
